Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Champions Oncolog (NQ: CSBR )

5.310 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.310
Bid (Size) 2.140 (1)
Ask (Size) 8.490 (2)
Prev. Close 5.310
Today's Range 5.310 - 5.310
52wk Range 3.750 - 7.320
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
Via ACCESSWIRE
Champions Oncology Announces the Addition of Brady Davis as President
Via ACCESSWIRE

Performance

YTD
+20.14%
+20.14%
1 Month
-5.85%
-5.85%
3 Month
-18.43%
-18.43%
6 Month
-3.63%
-3.63%
1 Year
-23.04%
-23.04%

More News

Read More
Champions Oncology Reports Quarterly Revenue of $12.6 Million
Via ACCESSWIRE
Earnings Outlook For Champions Oncology
Via Benzinga
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
Via ACCESSWIRE
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
Via ACCESSWIRE
Champions Oncology Earnings Perspective: Return On Capital Employed
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $13.1 Million
Via ACCESSWIRE
Champions Oncology's Earnings: A Preview
Via Benzinga
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
Via ACCESSWIRE
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023
Via ACCESSWIRE
Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development
Via ACCESSWIRE
Champions Oncology Announces $5M Stock Repurchase Program
Via ACCESSWIRE
Champions Oncology's Earnings: A Preview
Via Benzinga
Champions Oncology's Return On Capital Employed Insights
Via Benzinga
$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $12.8 Million
Via ACCESSWIRE
Earnings Scheduled For March 15, 2023
Via Benzinga
Champions Oncology to Announce Third Quarter Financial Results on Wednesday, March 15, 2023
Via ACCESSWIRE
Analyzing Champions Oncology's Short Interest
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
Via ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
Via ACCESSWIRE
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.